BiotechTube
Home/Septerna/Robert Lefkowitz
RL

Robert Lefkowitz

Scientific Founder

Septerna

Therapeutic Areas

EndocrinologyImmunology and InflammationMetabolic Diseases

Septerna Pipeline

DrugIndicationPhase
SEP-479 (PTH1R)HypoparathyroidismPhase 2
SEP-631 (MRGPRX2)Chronic Spontaneous Urticaria; Other mast cell diseasesPhase 2
TSHR ProgramGraves' Disease; Thyroid Eye DiseaseIND-Enabling
Metabolic Programs (GCGR + Undisclosed, GIPR, GLP-1R)Obesity and Other Cardiometabolic DiseasesPartnered / Discovery

Leadership Team at Septerna

JF
Jeffrey Finer
Chief Executive Officer and Co-Founder
GL
Gil Labrucherie
Chief Financial Officer
LB
Liz Bhatt
President and Chief Operating Officer
MA
Mark A. Wilson
Chief Legal Officer
SS
Samira Shaikhly
Chief People Officer
UK
Uwe Klein
Senior Vice President, Biological Sciences
JK
Jae Kim
Chief Medical Officer
DL
Daniel Long
Senior Vice President, Drug Discovery
AC
Arthur Christopoulos
Scientific Founder
PS
Patrick Sexton
Scientific Founder
View full Septerna profile